Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that its Ultra ...
Patients suffering from refractory ventricular tachycardia, a life-threating heart condition, who are not suitable for ...
Emirates News Agency on MSN
Vienna cardiologists pioneer hybrid technique to treat life-threatening arrhythmias
VIENNA, 11th April, 2026 (WAM)-- Cardiologists at University Hospital Vienna and MedUni Vienna have achieved a medical milestone by performing Austria's first hybrid procedure combining minimally ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.
InvestorsHub on MSN
Adagio Medical secures FDA clearance to broaden ventricular ablation study
Adagio Medical Holdings Inc. (NASDAQ:ADGM) said it has received Investigational Device Exemption (IDE) authorization from the ...
Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...
DPA Products help design engineers, OEMs, machine builders and system integrators stay ahead of the curve by combining visionary thinking with real-world practicality. Future-focused and reader-first, ...
In a remarkable clinical achievement, Kauvery Hospital, Alwarpet, successfully treated a 71-year-old man with multiple ...
Although emerging evidence supports 3-dimensional myocardial activation during atrial fibrillation (AF), human studies remain limited. We thus characterized the endocardial and epicardial left atrial ...
At Johns Hopkins in Baltimore, cardiologists are road-testing a patient-specific "digital twin" of a diseased heart, a computer model used to plan and guide catheter ablation for a dangerous rhythm ...
Working with "digital twins" of patients' hearts, doctors have improved cardiac ablation outcomes for patients with life-threatening arrhythmias. In the first clinical trials for cardiac digital twins ...
Scientists at Johns Hopkins University are creating virtual replicas of patients’ hearts so they can test how to fix a life-threatening irregular heartbeat before treating the real organ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results